Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Sélectionnez vos espèces et l'application
anti-Human PKD2 Anticorps:
anti-Mouse (Murine) PKD2 Anticorps:
anti-Rat (Rattus) PKD2 Anticorps:
Vous arrivez à notre recherche pré-filtrée.
Human Polyclonal PKD2 Primary Antibody pour IP, WB - ABIN152061
Liu, Evans, Britton, Zachary: The zinc-finger transcription factor, early growth response 3, mediates VEGF-induced angiogenesis. dans Oncogene 2008
Show all 8 Pubmed References
None of the Polymorphous low-grade adenocarcinoma (PLGA) lacking PRKD1 (Montrer PRKD1 Anticorps) somatic mutations or PRKD gene family rearrangements harboured somatic mutations in the kinase domains of the PRKD2 or PRKD3 (Montrer PRKD3 Anticorps) genes.
This study discovered and characterized a novel, highly conserved N-terminal domain, comprising 92 amino acids, which mediates dimerization of Protein Kinase D (PKD) isoforms, PKD1 (Montrer PKD1 Anticorps), PKD2, and PKD3 (Montrer PRKD3 Anticorps) monomers.
Studies indicate that the loss of protein kinase D PKD1 is thought to promote invasion and metastasis, while PKD2 and upregulated PKD3 (Montrer PRKD3 Anticorps) to be positive regulators of proliferation.
the knockdown of PKD2 reduces cell death and promotes polyploidization induced by PMA. PMA/PKD2-mediated necrosis via PARP (Montrer COL11A2 Anticorps) cleavage involves both SOD1 (Montrer SOD1 Anticorps)-dependent and -independent pathways.
The results implied that PKD2 silencing might inhibit migration of MCF7/DOX cells without affecting chemoresistance significantly
PRKD2 silencing induces glioma cell senescence via p53 (Montrer TP53 Anticorps)-dependent and -independent pathways.
Loss of PKD2 enhanced KC proliferative potential while loss of PKD3 (Montrer PRKD3 Anticorps) resulted in a progressive proliferation defect, loss of clonogenicity and diminished tissue regenerative ability.
Activation of PKD2 and further increase of PKD3 (Montrer PRKD3 Anticorps) activity leads to additional phosphorylation and inhibition of endogenous phosphatase slingshot 1L (Montrer SSH1 Anticorps).
Both PKD2 and GOLPH3 (Montrer GOLPH3 Anticorps) play important roles in the progression of human gliomas by promoting cell proliferation.
PKD2 controls secretion of MMP7 (Montrer MMP7 Anticorps) and 9 in an isoform-specific manner
Our studies demonstrate that PKD1 (Montrer PKD1 Anticorps)/2 is a key regulator of MVB maturation and exosome secretion, and constitutes a mediator of the DGK alpha (Montrer DGKA Anticorps) effect on MVB secretory traffic.
Results reveal that whereas protein kinase D1 (Montrer PRKD1 Anticorps) and protein kinase D2 are essential for neuronal polarity, there exists a functional redundancy between the two proteins.
PKD2 acted as an amplification checkpoint for antigen-stimulated digital cytokine responses and translated the differential strength of TCR signaling to determine the number of naive CD8 (Montrer CD8A Anticorps)(+) T cells that became effector cells.
Protein kinase D2 promotes in vitro osteoclast differentiation and fusion
A bioinformatic screen identified the serine-threonine kinase (Montrer CDK4 Anticorps) protein kinase D2 (PRKD2) as a potential effector of GABP in hematopoietic stem cells
Transcriptional profiling reveals the full consequences of PKD2 loss and maps in detail the selective, but critical, function for PKD2 in signalling by alpha/beta mature TCR complexes in peripheral T-cells.
PKD2 is a common signaling target downstream of various agonist receptors in platelets and G(q)-mediated signals along with calcium and novel PKC isoforms, in particular, PKCdelta (Montrer PKCd Anticorps) activate PKD2 in platelets.
Data demonstrate that, unlike PKD1 (Montrer PKD1 Anticorps), PKD2 catalytic activity is dispensable for normal embryogenesis.
PKD2, like PKD (Montrer PRKD1 Anticorps), facilitates mitogenesis in 3T3 cells
The protein encoded by this gene belongs to the protein kinase D (PKD) family of serine/threonine protein kinases. This kinase can be activated by phorbol esters as well as by gastrin via the cholecystokinin B receptor (CCKBR) in gastric cancer cells. It can bind to diacylglycerol (DAG) in the trans-Golgi network (TGN) and may regulate basolateral membrane protein exit from TGN. Alternative splicing results in multiple transcript variants encoding different isoforms.
serine/threonine-protein kinase D2
, protein kinase D2
, serine/threonine-protein kinase D2-like